HC Wainwright reissued their buy rating on shares of Silence Therapeutics (NASDAQ:SLN – Free Report) in a research note ...

Silence Therapeutics PLC Sponsored ADR (SLN) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful ...

Silence Therapeutics (NASDAQ:SLN – Get Free Report) is expected to be announcing its earnings results before the market opens ...

Today is shaping up negative for Silence Therapeutics plc ( NASDAQ:SLN ) shareholders, with the analysts delivering a... LONDON, March 05, 2025--Silence Therapeutics plc, Nasdaq: SLN ("Silence" or ...

SLN has started construction and mobilization for a 10,000 square foot expanded terminal. Salina Airport Authority Executive ...

By Dinasena Rathugamage The Navy is making preparations for the Katchatheevu festival, scheduled to be held on 14 and 15 March, at St. Anthony’s shrine. The Navy will provide drinking water, ...

Good morning and good afternoon, everyone. Thank you for joining us today. My name is Gem Hopkins, Vice President of Investor Relations and Corporate Communications at Silence. Joining me on today ...

Stay updated on market trends for SLN. Silence Therapeutics' Phase 2 data shows zerlasiran achieves over 80% Lp(a) reduction in ASCVD patients but faces dosing frequency challenges.